This is a single center prospective study of 30 patients undergoing elective heart bypass surgery (CABG) with at least two vein grafts from the leg (SVG). The purpose of this ex vivo study is to evaluate the function of vein grafts from small tissue samples treated with a pressure syringe and a non-pressure syringe. Syringes are routinely used to flush out the veins in preparation of bypass grafting. It is unknown if different levels of pressure in the syringe affect the vein or damage the vein. Small sections of tissue samples which are normally discarded will be obtained immediately after retrieval from the leg and before grafting to the heart. Tissue samples will be taken to the laboratory for study. There are no clinical endpoints in this study, however, clinical information will be obtained from the Society of Thoracic Surgeons database and will include demographics, risk factors, and perioperative outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
30
Use of Maquet Vasoshield Pressure-limiting syringe on SVG
Use of non-regulated syringe on SVG
Cardiothoracic Surgery Research Laboratory
Atlanta, Georgia, United States
Emory University Hospital Midtown
Atlanta, Georgia, United States
SVG vascular contractility
Time frame: Day of surgery
Nitric oxide metabolite levels
Time frame: Day of surgery
Major adverse cardiac events
Time frame: 6 months and 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.